Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Freeze-dried Live Attenuated Measles and Rubella Combined Vaccine "Takeda" Special Drug Use Surveillance of Vaccinees After the First Vaccination

NCT02151773 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02151773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02151773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Freeze-dried Live Attenuated Measles and Rubella Combined Vaccine "Takeda" Special Drug Use Surveillance of Vaccinees After the First Vaccination
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
February 28, 2006
Completion date
April 30, 2009
Enrollment
3,493 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

measles/rubella